150 related articles for article (PubMed ID: 37204502)
1. Endoscopic retrograde cholangiopancreatography outcomes in inflammatory bowel disease patients: a 12-year analysis of a national database.
Deshmukh A; Desai PM; Chrusciel T; Nwankwo E; Tripathi R; Cheesman AR
Int J Colorectal Dis; 2023 May; 38(1):137. PubMed ID: 37204502
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of endoscopic retrograde cholangiopancreatography in patients with inflammatory bowel disease: a nationwide study.
Kalligeros M; Kröner PT; Farraye FA; Desalermos A
Int J Colorectal Dis; 2023 Jan; 38(1):23. PubMed ID: 36692549
[TBL] [Abstract][Full Text] [Related]
3. Temporal trend and factors associated with post-endoscopic retrograde cholangiopancreatography pancreatitis in children in the USA: a nationwide, retrospective cohort study.
Zhu R; Wu S; Xu J; Wang R; Cheng Y; Xu Y; Chen C; Wu C
Eur J Pediatr; 2023 May; 182(5):2273-2282. PubMed ID: 36872379
[TBL] [Abstract][Full Text] [Related]
4. End-stage renal disease is associated with increased post endoscopic retrograde cholangiopancreatography adverse events in hospitalized patients.
Sawas T; Bazerbachi F; Haffar S; Cho WK; Levy MJ; Martin JA; Petersen BT; Topazian MD; Chandrasekhara V; Abu Dayyeh BK
World J Gastroenterol; 2018 Nov; 24(41):4691-4697. PubMed ID: 30416316
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic retrograde cholangiopancreatography-related adverse events in Korea: A nationwide assessment.
Jang DK; Kim J; Paik CN; Kim JW; Lee TH; Jang JY; Yoon SB; Lee JK
United European Gastroenterol J; 2022 Feb; 10(1):73-79. PubMed ID: 34953054
[TBL] [Abstract][Full Text] [Related]
6. The impact of COVID-19 on hospitalizations that underwent endoscopic retrograde cholangiopancreatography in the United States.
Dahiya DS; Pinnam BSM; Chandan S; Gangwani MK; Ali H; Deliwala S; Bapaye J; Aziz M; Merza N; Inamdar S; Al-Haddad M; Sharma N
Surg Endosc; 2024 Jan; 38(1):202-211. PubMed ID: 37957298
[TBL] [Abstract][Full Text] [Related]
7. Decompensated cirrhosis may be a risk factor for adverse events in endoscopic retrograde cholangiopancreatography.
Inamdar S; Berzin TM; Berkowitz J; Sejpal DV; Sawhney MS; Chutanni R; Pleskow DK; Trindade AJ
Liver Int; 2016 Oct; 36(10):1457-63. PubMed ID: 26913829
[TBL] [Abstract][Full Text] [Related]
8. Multicenter prospective cohort study of adverse events associated with biliary endoscopic retrograde cholangiopancreatography: Incidence of adverse events and preventive measures for post-endoscopic retrograde cholangiopancreatography pancreatitis.
Fujita K; Yazumi S; Matsumoto H; Asada M; Nebiki H; Matsumoto K; Maruo T; Takenaka M; Tomoda T; Onoyama T; Kurita A; Ueki T; Katayama T; Kawamura T; Kawamoto H;
Dig Endosc; 2022 Sep; 34(6):1198-1204. PubMed ID: 34963021
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of socioeconomic and healthcare disparities on same admission cholecystectomy after endoscopic retrograde cholangiopancreatography among patients with acute gallstone pancreatitis.
Chouairi F; McCarty TR; Hathorn KE; Sharma P; Aslanian HR; Jamidar PA; Thompson CC; Muniraj T
Surg Endosc; 2022 Jan; 36(1):274-281. PubMed ID: 33481109
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic Retrograde Cholangiopancreatography (ERCP) in Patients With Liver Cirrhosis: Analysis of Trends and Outcomes From the National Inpatient Sample Database.
Solanki S; Kichloo A; Dahiya DS; Solanki D; Singh J; Wani F; Albosta M; Ghimire S; Haq KF; Khan HMA; Jafri SM; Siddiqui MA; Zuchelli T
J Clin Gastroenterol; 2022 Aug; 56(7):618-626. PubMed ID: 34107514
[TBL] [Abstract][Full Text] [Related]
11. Development of an Online App to Predict Post-Endoscopic Retrograde Cholangiopancreatography Adverse Events Using a Single-Center Retrospective Cohort.
Rodrigues-Pinto E; Morais R; Sousa-Pinto B; Ferreira da Silva J; Costa-Moreira P; Santos AL; Silva M; Coelho R; Gaspar R; Peixoto A; Dias E; Baron TH; Vilas-Boas F; Moutinho-Ribeiro P; Pereira P; Macedo G
Dig Dis; 2021; 39(3):283-293. PubMed ID: 33429393
[TBL] [Abstract][Full Text] [Related]
12. Pre- and post-procedure risk prediction models for post-endoscopic retrograde cholangiopancreatography pancreatitis.
Park CH; Park SW; Yang MJ; Moon SH; Park DH
Surg Endosc; 2022 Mar; 36(3):2052-2061. PubMed ID: 34231067
[TBL] [Abstract][Full Text] [Related]
13. Racial disparities in endoscopic retrograde cholangiopancreatography (ERCP) utilization in the United States: are we getting better?
Dahiya DS; Perisetti A; Sharma N; Inamdar S; Goyal H; Singh A; Rotundo L; Garg R; Cheng CI; Pisipati S; Al-Haddad M; Sanaka M
Surg Endosc; 2023 Jan; 37(1):421-433. PubMed ID: 35986223
[TBL] [Abstract][Full Text] [Related]
14. Hospital costs, length of stay and prevalence of hip and knee arthroplasty in patients with inflammatory bowel disease.
Ehrenpreis ED; Zhou Y
World J Gastroenterol; 2017 Jul; 23(26):4752-4758. PubMed ID: 28765696
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes and predictors for 30-day readmissions of endoscopic retrograde cholangiopancreatography in the United States.
Dahiya DS; Pinnam BSM; Chandan S; Gangwani MK; Ali H; Gopakumar H; Aziz M; Bapaye J; Al-Haddad M; Sharma NR
J Gastroenterol Hepatol; 2024 Jan; 39(1):141-148. PubMed ID: 37743640
[TBL] [Abstract][Full Text] [Related]
16. Outcomes and risk factors for ERCP-related complications in a predominantly black urban population.
Kwak N; Yeoun D; Arroyo-Mercado F; Mubarak G; Cheung D; Vignesh S
BMJ Open Gastroenterol; 2020 Sep; 7(1):. PubMed ID: 32943462
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for post-endoscopic retrograde cholangiopancreatography (ERCP) abdominal pain in patients without post-ERCP pancreatitis.
Chen MJ; Zheng RH; Cao J; Yao YL; Wang L; Zou XP
Hepatobiliary Pancreat Dis Int; 2022 Jun; 21(3):285-292. PubMed ID: 34924299
[TBL] [Abstract][Full Text] [Related]
18. Risk factors of pancreatitis after endoscopic retrograde cholangiopancreatography in patients with biliary tract diseases.
Chi JY; Ma LY; Zou JC; Ma YF
BMC Surg; 2023 Mar; 23(1):62. PubMed ID: 36959589
[TBL] [Abstract][Full Text] [Related]
19. Role of immunosuppression in post-endoscopic retrograde cholangiopancreatography pancreatitis after liver transplantation: a retrospective analysis.
Law R; Leal C; Dayyeh BA; Leise MD; Balderramo D; Baron TH; Cardenas A
Liver Transpl; 2013 Dec; 19(12):1354-60. PubMed ID: 24115362
[TBL] [Abstract][Full Text] [Related]
20. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
